Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in elderly overweight or obese patients with mild cognitive impairment
ChiCTR2600132779Phase 4Completed
- Sponsor
- Huadong Hospital, Fudan University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in Mild Cognitive Impairment (MCI), Overweight and obesity (2 arms), sponsored by Huadong Hospital, Fudan University. Primary endpoint: Functional magnetic resonance imaging. Started Oct 2024; status: completed.
02
Drugs
metformin
03
Conditions
Mild Cognitive Impairment (MCI)Overweightobesity
Beyond the preview
Go deeper on ChiCTR2600132779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132779.